Dee Michael E
Known title: Chief Financial OfficerCIK: 0001756027
Dee Michael E's purchase track record
Dee Michael E has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/15/2021 | PCT | $75K | -50.2% | -24.0% | -14.4% |
| 8/20/2021 | PCT | $89K | +4.8% | -49.6% | -2.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PCT | ▼ Sell | Gift | 13,000 | $0 | 12/30/2021 | View on chart |
| PCT | ▼ Sell | Gift | 3,000 | $0 | 12/30/2021 | View on chart |
| PCT | ▼ Sell | Gift | 3,000 | $0 | 12/30/2021 | View on chart |
| PCT | ▼ Sell | Gift | 3,000 | $0 | 12/30/2021 | View on chart |
| PCT | ▼ Sell | Gift | 3,000 | $0 | 12/30/2021 | View on chart |
| PCT | ▲ Buy | Open Market | 7,160 | $75K | 11/15/2021 | View on chart |
| PCT | ▼ Sell | Tax Withholding | 131,166 | $1.7M | 9/17/2021 | View on chart |
| PCT | ▲ Buy | Open Market | 3,190 | $39K | 8/24/2021 | View on chart |
| PCT | ▲ Buy | Open Market | 4,190 | $50K | 8/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
PureCycle Faces Delays in Food Packaging Demand
PureCycle Technologies is facing a longer wait for demand in the food packaging sector, which adds to commercialization risks. Recent earnings discussions highlight these challenges, contributing to a significant recent decline in the stock price. The company continues to navigate the gap between its technology and market adoption.
PureCycle Faces Delays in Food Packaging Demand. PureCycle Technologies is facing a longer wait for demand in the food packaging sector, which adds to commercialization risks. Recent earnings discussions highlight these challenges, contributing to a significant recent decline in the stock price. The company continues to navigate the gap between its technology and market adoption.